Interim report Q1: Improved profitability and attractive growth opportunities

Net sales fell 2% year over year to SEK 811 million, while organic growth was -1% versus 11% previously, indicating softer demand in a cautious market. Adjusted EBIT improved to SEK 28 million from SEK 21 million and the margin widened to 3.5% from 2.5%, but cash flow from operating activities remained negative at SEK -5 million. Management highlighted a seasonally weak quarter and a challenging business climate, pointing to continued pressure on near-term growth.

Analysis

The key read-through is not simply “soft demand,” but that pricing discipline is probably masking a more fragile volume backdrop. In a low-growth environment, modest margin improvement can be misleading because fixed-cost absorption is still deteriorating; if volumes stay negative for another quarter, the operating leverage can flip quickly and erase most of the current margin gain. That makes the business look more cyclical than the headline EBIT improvement suggests.

The second-order effect is pressure on smaller, less diversified competitors and distributors that depend on transaction frequency rather than mix. If the company is defending share via promotions or delayed price increases, the pain will show up first in channel inventory and working capital, then in supplier orders, which can create a lagged downdraft over the next 1-2 quarters. The cash flow profile also implies limited room for aggressive buybacks, M&A, or meaningful reinvestment while demand remains weak.

The near-term catalyst set is mostly binary: a weather-normalized improvement in activity, any evidence of order stabilization, or a management tone shift toward price realization could drive a relief rally within days. Absent that, this is a “show me” story for the next 2 reporting periods, with downside risk if the market starts pricing a second-half volume reset. Consensus may be underestimating how long caution persists once customers delay discretionary purchases; in that scenario, the eventual recovery is slower than the current quarter-to-quarter noise suggests, but the selloff could still be overdone if margins hold above breakeven and cash conversion normalizes.

Key Decisions for Investors

• Avoid chasing the name on the headline margin beat; wait 2-4 weeks for channel checks and management commentary on Q2 run-rate before initiating longs.
• If liquidity is adequate, consider a short against a stronger peer basket in the same end-market over the next 1-2 months; the setup favors relative underperformance if demand remains weak.
• Use any 5-8% rally on a better-than-expected monthly sales print to fade via short-term put spreads or a tactical short, with a 6-8 week horizon.
• If you want to express a contrarian upside view, buy only on confirmation of sequential organic growth turning positive; target a 2:1 reward/risk into the next earnings release.